Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7201
Rail Vision
RVSN
$7.28M
| $2.31K | ﹤0.01% |
500
| – | – |
2025 Q3
3 quarters
|
|
7202
ProShares Smart Materials ETF
TINT
$1.9M
| $2.28K | ﹤0.01% |
57
+56
| +5,600% | +$2.25K |
2023 Q4
10 quarters
|
|
7203
Neuberger Emerging Markets Debt Hard Currency ETF
NEMD
$136M
| $2.28K | ﹤0.01% |
43
| – | – |
2025 Q3
3 quarters
|
|
7204
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$153M
| $2.28K | ﹤0.01% |
68
-228
| -77% | -$7.54K |
2020 Q4
22 quarters
|
|
7205
BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF
XSVN
$548M
| $2.27K | ﹤0.01% |
48
| – | – |
2025 Q1
5 quarters
|
|
7206
Calidi Biotherapeutics
CLDI
$2.45M
| $2.25K | ﹤0.01% |
828
+236
| +40% | +$763 |
2023 Q4
10 quarters
|
|
7207
Alliance Entertainment
AENT
$230M
| $2.25K | ﹤0.01% |
385
+196
| +104% | +$1.27K |
2026 Q1
1 quarter
|
|
7208
Tempest Therapeutics
TPST
$12.7M
| $2.24K | ﹤0.01% |
2,022
-36
| -2% | -$59 |
2013 Q4
50 quarters
|
|
7209
Global X Brazil Active ETF
BRAZ
$12.5M
| $2.23K | ﹤0.01% |
+76
| New | +$2.41K |
2026 Q2
0 quarters
|
|
7210
REX-Osprey XRP ETF
XRPR
$52.1M
| $2.19K | ﹤0.01% |
+255
| New | +$2.73K |
2026 Q2
0 quarters
|
|
7211
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$23.1M
| $2.17K | ﹤0.01% |
+600
| New | +$2.83K |
2026 Q2
0 quarters
|
|
7212
Quest Resource Holding
QRHC
$28.5M
| $2.16K | ﹤0.01% |
1,718
+17
| +1% | +$20 |
2020 Q2
24 quarters
|
|
7213
Energys Group
ENGS
$150M
| $2.14K | ﹤0.01% |
881
| – | – |
2025 Q4
2 quarters
|
|
7214
ReWalk Robotics
LFWD
$17.6M
| $2.1K | ﹤0.01% |
274
+66
| +32% | +$462 |
2023 Q1
13 quarters
|
|
7215
Sunlands Technology
STG
$34.6M
| $2.08K | ﹤0.01% |
532
-324
| -38% | -$1.1K |
2024 Q2
8 quarters
|
|
7216
Heidmar Maritime Holdings
HMR
$106M
| $2.08K | ﹤0.01% |
+1,626
| New | +$1.73K |
2026 Q2
0 quarters
|
|
7217
TCW High Yield Bond ETF
HYBX
$27.6M
| $2.08K | ﹤0.01% |
+70
| New | +$2.09K |
2026 Q2
0 quarters
|
|
7218
Fundstrat Granny Shots US Small & Mid-Cap ETF
GRNJ
$523M
| $2.08K | ﹤0.01% |
+66
| New | +$1.97K |
2026 Q2
0 quarters
|
|
7219
Research Frontiers
REFR
$19.3M
| $2.06K | ﹤0.01% |
3,967
+32
| +0.8% | +$26 |
2013 Q4
50 quarters
|
|
7220
Fidelity Magellan ETF
FMAG
$245M
| $2.06K | ﹤0.01% |
+56
| New | +$1.99K |
2026 Q2
0 quarters
|
|
7221
VistaShares Target 15 TEPRTantrum Contrarian Distribution ETF
TPRY
$4.26M
| $2.06K | ﹤0.01% |
+100
| New | +$1.99K |
2026 Q2
0 quarters
|
|
7222
Defiance S&P 500 Income Target ETF
SPYT
$170M
| $2.06K | ﹤0.01% |
+117
| New | +$2.03K |
2026 Q2
0 quarters
|
|
7223
YieldMax COIN Option Income Strategy ETF
CONY
$372M
| $2.04K | ﹤0.01% |
108
| – | – |
2026 Q1
1 quarter
|
|
7224
Aethlon Medical
AEMD
$4.15M
| $2.04K | ﹤0.01% |
494
+85
| +21% | +$880 |
2025 Q4
2 quarters
|
|
7225
Indonesia Energy Corp
INDO
$42.6M
| $2.03K | ﹤0.01% |
740
| – | – |
2024 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.